
May 12, 2026
Dr. James F. Howard Jr. Leads Global Study Advancing Treatment for Myasthenia Gravis
A major advancement in the treatment of generalized myasthenia gravis (gMG) is expanding options for patients worldwide, supported by the leadership of UNC Neurology’s Dr. James F. Howard Jr. The U.S. Food and Drug Administration recently approved an expanded indication for efgartigimod (VYVGART®), making it available to all adult patients with gMG regardless of antibody …















































































